Journals / Osteoporoz Dünyasından / 2003 / Cilt: 9 - Sayı: 4

The evaluation of efficacy of calcitriol on bone mineral density, pain and quality of life in postmenopausal osteoporotic patients with or without depression

Depresyonlu postmenopozal osteoporozlu olgularda kalsitriolün, kemik mineral yoğunluğu, ağrı ve yaşam kalitesi üzerine etkisinin değerlendirilmesi

Pages
129–136
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, postmenopausal bone loss was higher and the response to calcitriol treatment was better in patients with depression.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to determine whether depression was affect on bone loss in postmenopausal osteoporotic (PMO) women and response to calcitriol treatment in this patients.
📊
Key Findings & Data:Seventy two females (mean age 65 ± 6.9) were included in this study.
💡
Conclusion & Impact:In conclusion, postmenopausal bone loss was higher and the response to calcitriol treatment was better in patients with depression.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kemik yoğunluğu · Kalsitriol · Depresyon

Abstract

The aim of this study was to determine whether depression was affect on bone loss in postmenopausal osteoporotic (PMO) women and response to calcitriol treatment in this patients. Seventy two females (mean age 65 ± 6.9) were included in this study. Out of these patients, 27 (37.5%) had depression, 45 (62.5%) were normal. All cases were evaluated by DXA, Hamilton depression scale, Short Form-36 (SF-36) scale and visual analog scale. In the patients with depression, L1-L4 t-score (-3.29 ± 1.07), femur total t-score (-2.60 ± 1.00) and z-score (-0.97 ± 0.82) were significantly lower than PMO patients without depression (respectively; -2.71 ± 0.83, -1.86 ± 1.16 and -0.50 ± 0.91). Improvement of t- and z- scores in both groups were statistically significant after calcitriol treatment. Improvement of L1-L4 t- and z-scores and femur neck t-score were higher in patients with depression. SF-36 scores (75.9 ± 19.8) were lower in patients with depression than patients without depression (86.5 ± 14.4) (p=0.041). Negative correlations between Hamilton score and L1-L4 z-score (R=-0.432, p=0.024), femur neck t-score (R=-0.528, p=0.005) were found before treatment. Improvement of pain in both groups were similar. In conclusion, postmenopausal bone loss was higher and the response to calcitriol treatment was better in patients with depression.

Özet

Bu çalışmanın amacı, postmenopozal osteoporotik kadınlarda depresyonun kemik kaybına olan etkisini ve bu hastalarda kalsitriol tedavisine verilen cevabı araştırmaktır. Bu çalışmaya 72 kadın hasta alınmıştır ( ortalama yaş 65 ± 6.9). Bu hastaların 27'sinde depresyon tespit edildi (37.5%) ve 45'inin depresyonu yoktu (62.5 %). Bütün hastalar, DEXA, Hamilton depresyon skalası, Short Form-36 ve Vizüel Analog Skalası ile değerlendirildiler. Depresyonlu hastalarda, L1-L4 T skor (-3.29 ± 1.07), Femur total T skor (-2.60 ±1.00) ve Z skor (-0.97 ±0.82) değerleri, depresyonu olmayan hastalardaki değerlere göre (sırasıyla, -2.71±0.83, -1.86±1.16 ve -0.50 ±0.91) anlamlı olarak düşük idi. Kalsitriol tedavisinden sonra her iki grubun T ve Z skorlarında anlamlı artış oldu. Depresyonlu hastalardaki L1-L4 T skoru ve Z skoru ve Femur total T skor değerleri daha fazla arttı. SF-36 skorları depresyonlu hastalarda (75.9±19.8) depresyonsuz hastalara göre (86.5±14.4) daha düşük saptandı (p= 0.041). Tedaviden önce Hamilton skoru ile L1-4 Z skoru (R= -0.432, p=0.024), Femur total T skoru (R=-0.528, p= 0.005) arasında negatif korelasyon bulundu. Ağrının düzelme derecesi her iki grupta da eşitti. Sonuç olarak, depresyonlu hastalarda postmenopozal kemik kaybının daha fazla olduğu ve bu hastaların kalsitriol tedavisine cevabının daha fazla olduğu sonucuna varıldı.

🔖

Cite This Article

KOYUNCU, H., AKTAŞ, İ., DİNÇ, A., ÖZKUL, İ., AYDIN, T., YÜCEL, E., KOCAMAN, Ö., TOROS, H. (2003). The evaluation of efficacy of calcitriol on bone mineral density, pain and quality of life in postmenopausal osteoporotic patients with or without depression. Osteoporoz Dünyasından, Cilt: 9 - Sayı: 4, 129–136. https://ajindex.com/articles/286872

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Eryavuz Sarıdoğan M. Osteoporozun Tanımı, Sınıflandırması ve Epidemiyolojik Çalışmalar. Türkiye Klinikleri Fiziksel Tıp ve Rehabilitasyon ( Osteoporoz Özel Sayısı) 2002
  2. 1(2): 1-10 2. Vrkljan M, Thaller V, Lovricevic I et al. Depressive disorder as possible risk factor of osteoporosis. Coll Antropol 2001 Dec
  3. 25(2):485-492. 3. Lyles KW.Osteoporosis and depression: shedding more light upon a complex relationship. Journal of the American Geriatrics Society 2001
  4. 49 (6): 827. 4. Cortet B, Roches E, Logier R et al. Evaluation of spinal curvatures after a recent osteoporotic vertebral fracture. Joint Bone Spine 2002
  5. 69 (2): 201-208. 5. Lips P, Cooper C, Agnusdei D et al. Quality of life in patients with vertebral fractures: Validation of the Quality of life questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Osteoporos Int 1999
  6. Murrel P, Todd CJ, Martin A et al. Postal administration compared with nurse-supported administration of the QUALEFFO-41 in a population sample: Comparison of results and assessment of psychometric properties. Osteoporos Int 2001
  7. Salkeld G, Cameron ID, Cumming RG, et al: Quality of life related to fear of falling and hip fracture in older women. BMJ 2000
  8. 341 8. Canalis E: Novel treatments for osteoporosis. The Journal of Clinical Investigation 2000, 106 (2):177-179. 9. Malavolta N, Zanardi M, Veronesi M et al. Calcitriol and alendronate combination treatment in postmenopausal women with low bone mass. Int J Tissue React 2000
  9. Johnston CC, Melton III LJ. Bone Densitometry. Riggs BL, Melton III LJ (Eds). Osteoporosis: Etiology, Diagnosis, and Management. Lippincott-Raven 1995
  10. Hui SL, Slemenda CW, Johnston CC. Baseline measurements of bone mass predicts fracture in white women. Ann Intern Med 1989
  11. Heikinhimo RJ, Inkovaara JA, Harju EJ, et al: Annual injections of vitamin D and fractures of aged bones. Calcif Tissue Int 1992
  12. Dawson- Hughes B. Prevention. Riggs BL, Melton III LJ (Eds). Osteoporosis: Etiology, Diagnosis and Management. Lippincott- Raven 1995
  13. Eskiyurt N: Osteoporozdan Korunma. Modern Tıp Seminerleri:19 Osteoporoz. Gökçe-Kutsal Y (Ed). Güneş Kitabevi, Ankara 2001: 212-223. 15. Hall SE, Criddle A, Comito TL, Prince RL. A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture. Osteoporos Int 1999
  14. Gold DT, Drez